The estimated Net Worth of Group Management L.L.C.Carl... is at least $1.05 Миллиард dollars as of 31 January 2014. Group Carl owns over 2,333,333 units of Cencora stock worth over $964,515,079 and over the last 11 years Group sold COR stock worth over $89,420,372.
Group has made over 2 trades of the Cencora stock since 2014, according to the Form 4 filled with the SEC. Most recently Group sold 4,083,122 units of COR stock worth $89,420,372 on 18 September 2014.
The largest trade Group's ever made was selling 4,083,122 units of Cencora stock on 18 September 2014 worth over $89,420,372. On average, Group trades about 802,057 units every 29 days since 2013. As of 31 January 2014 Group still owns at least 4,083,122 units of Cencora stock.
You can see the complete history of Group Carl stock trades at the bottom of the page.
Group's mailing address filed with the SEC is 1001 Pennsylvania Ave NW, Washington, DC 20004, USA.
Over the last 14 years, insiders at Cencora have traded over $67,682,023 worth of Cencora stock and bought 34,206 units worth $1,080,918 . The most active insiders traders include Realty Iii, Gp, L.L.C.Carly..., Iv Aiv Gp, L.L.C.Crp Iv Aiv... и Group Management L.L.C.Carl.... On average, Cencora executives and independent directors trade stock every 13 days with the average trade being worth of $18,365,869. The most recent stock trade was executed by Brian Warren on 5 November 2021, trading 850 units of COR stock currently worth $130,577.
amerisourcebergen is driving innovative partnerships with global manufacturers, providers and pharmacies to improve product access and efficiency throughout the healthcare supply chain and enhance patient care. as the leader in global sourcing and distribution, we source and distribute brand, generic, specialty, otc pharmaceuticals and other healthcare products. we increase the effectiveness and efficiency of your supply chain by ensuring products are delivered securely, consistently and cost-effectively, improving product access for pharmacies, providers and patients. our pharmacy solutions result in greater operational efficiency, cost control, growth opportunities and patient safety. our provider solutions drive operational efficiency, financial performance and improve quality of care. our manufacturer solutions maximize success at every stage of the product lifecycle. amerisourcebergen. where knowledge, reach and partnership shape healthcare delivery.
Cencora executives and other stock owners filed with the SEC include: